The Relation Between Serum Level of Amioterminal Propeptide of Type I Procollagen and Diastolic Dysfunction in Hypertensive Patients Without Diabetes Mellitus
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Hypertension
Related studies linked through entity extraction aliases.
Hypertension and Cardiovascular Risk Factors
- Status
- COMPLETED
- Phase
- PHASE4
Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.
- Status
- COMPLETED
- Phase
- PHASE4
Antialbuminuric Effects of Valsartan and Lisinopril
- Status
- TERMINATED
- Phase
- PHASE4
Antiproteinuric Effect of Valsartan and Lisinopril
- Status
- COMPLETED
- Phase
- PHASE4
Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Two Treatment Strategies in Hypertensive Patients
- Status
- COMPLETED
- Phase
- PHASE4
A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg
- Status
- COMPLETED
- Phase
- PHASE3
A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction
- Status
- COMPLETED
- Phase
- PHASE4
VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women
- Status
- COMPLETED
- Phase
- PHASE4
A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
- Status
- TERMINATED
- Phase
- PHASE4
A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
- Status
- COMPLETED
- Phase
- PHASE3
VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis
- Status
- COMPLETED
- Phase
- PHASE3
VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
A Study Of Valsartan Used To Treat Hypertension For Up To 13 Months In Hypertensive Children Ages 6 - 16 Years Of Age
- Status
- COMPLETED
- Phase
- PHASE3
A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension
- Status
- COMPLETED
- Phase
- PHASE3